Novo Nordisk has formally launched a program to cut the cost of insulin for diabetic patients and is offering half off its own generic insulin brand, the drugmaker said Jan. 1.
Under the My$99Insulin Program, Novo Nordisk will allow patients to buy up to three vials of its insulin or two packs of its insulin pens for $99. Eligible patients with and without insurance can enroll online at NovoCare.com.
Novo Nordisk is offering a 50 percent discount of its own NovoLog and NovoLog Mix generic insulins.
"We know some people still struggle to afford their insulin, and we want to help. We've talked to people, including those who have been critical of us, and it's clear there is no one solution that will work for everyone, and people need options," said Doug Langa, executive vice president of North American operations and president of Novo Nordisk. "That's why today, we have made available additional options recognizing the different situations that make insulin unaffordable or inaccessible."
More articles on pharmacy:
Amazon's PillPack seeking to win over new insurers in 2020
Roche buys international rights to Sarepta's Duchenne drug for $750M
Former Aegerion sales rep defrauded insurers, stole identities to push cholesterol drug